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Abstract
Background: The spike protein (S) of SARS Coronavirus (SARS-CoV) mediates entry of the virus
into target cells, including receptor binding and membrane fusion. Close to or in the viral
membrane, the S protein contains three distinct motifs: a juxtamembrane aromatic part, a central
highly hydrophobic stretch and a cysteine rich motif. Here, we investigate the role of aromatic and
hydrophobic parts of S in the entry of SARS CoV and in cell-cell fusion. This was investigated using
the previously described SARS pseudotyped particles system (SARSpp) and by fluorescence-based
cell-cell fusion assays.
Results: Mutagenesis showed that the aromatic domain was crucial for SARSpp entry into cells,
with a likely role in pore enlargement.
Introduction of lysine residues in the hydrophobic stretch of S also resulted in a block of entry,
suggesting the borders of the actual transmembrane domain. Surprisingly, replacement of a glycine
residue, situated close to the aromatic domain, with a lysine residue was tolerated, whereas the
introduction of a lysine adjacent to the glycine, was not. In a model, we propose that during fusion,
the lateral flexibility of the transmembrane domain plays a critical role, as do the tryptophans and
the cysteines.
Conclusions: The aromatic domain plays a crucial role in the entry of SARS CoV into target cells.
The positioning of the aromatic domain and the hydrophobic domain relative to each other is
another essential characteristic of this membrane fusion process.
Background
The mechanism by which the viral spike proteins mediate
the initial stages of membrane fusion is fairly well under-
stood for a number of viruses. Currently, there are three
classes of viral fusion proteins recognized. Although struc-
turally unrelated, the viral fusion proteins of all classes
refold to establish a conformation that brings the fusion
peptide and the transmembrane domain (TMD) in close
proximity, thus initializing membrane fusion [1].
As the initial stages of viral membrane fusion, including
the refolding of the spike proteins, are well-understood,
the exact mechanism by which the membranes merge
remains unclear. It is very likely that the transmembrane
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domains (TMDs) or amino acid residues adjacent to the
TMDs of viral fusion proteins, play a role in this process
[2]. For instance, Influenza HA molecules that are
anchored to a membrane through a GPI anchor in stead
of their wild type TMD, are unable to complete the fusion
process. Rather, membrane fusion is halted at the hemifu-
sion stage [3-5]. In addition, it has been shown that gly-
cine residues of the TMD of the vesicular stomatitis virus
glycoprotein (VSV-G), play a critical role in membrane
fusion [6]. Furthermore, it has been shown that the mem-
brane-proximal domain of GP41, the fusion protein of
human immunodeficiency virus, is important for fusion
activity [7,8]. In particular, aromatic residues have been
shown to be involved in the process of fusion pore dila-
tion [7]. Likewise, palmitoylated cysteines, situated in or
close to the viral membrane, have been implicated in the
fusion process of coronavirus [9-12] and influenza virus
[13]. We have shown that the TMDs of coronavirus spike
proteins are also crucial for membrane fusion activity. By
swapping the TMD of severe acute respiratory syndrome
coronavirus (SARS CoV) spike for that of VSV-G, we have
shown that both entry of SARS pseudoparticles (SARSpp)
and SARS CoV spike protein mediated cell-cell fusion
depends on the presence of the TMD of the spike [14].
The TMD of the SARS CoV spike protein consists of three
domains: 1) a highly conserved N-terminal aromatic
(tryptophan) rich stretch, 2) a hydrophobic core sequence
and 3) a C-terminal cysteine rich domain. These domains
are highly conserved in all coronaviruses (see Figure 1A).
In this paper we describe an extensive mutagenesis study
of the aromatic domain of SARS CoV S and the effect of
these mutations on entry and fusion. In addition, we have
tried to map the amino acids that are actually in the mem-
brane by introducing a charged lysine residue at different
positions in the predicted TMD region. We measured the
capacity of the mutated spike proteins to mediate cell
entry of virus like particles using our previously described
SARSpp assay [14]. In addition, we determined the oligo-
meric state of the non-active mutants. The mutants con-
cerning the aromatic domain were further analyzed using
fluorescent dye transfer assays. The data presented here
show that specific amino acids in or close to the TMD are
crucial for membrane fusion activity of SARS CoV.
Results
Sequence analysis of the TMD of coronavirus spike pro-
teins reveals a high conservation rate. In Figure 1A, an
alignment is shown of the transmembrane domains of
several coronavirus spike proteins, of which at least one
virus of each group is included. Evidently, the aromatic
and cysteine domains are conserved between CoVs. To
investigate the roles of the aromatic domain in SARS CoV
spike-mediated entry, we performed an extensive muta-
genesis on the spike TMD. The mutants that were gener-
ated are listed in Figure 1B.
Mutagenesis of the aromatic domain of SARS S
Previously, the aromatic domain of HIV gp41 has been
shown to be important for the entry of HIV into target
cells [8], in particular for the dilation of fusion pores [7].
Recently, Howard et al. have shown that also the aromatic
residues in the juxtamembrane domain of SARS CoV S are
important for entry of SARS CoV [15]. By creating mutant
SΔARO, we wanted to investigate the importance of the
aromatic domain in SARS S-mediated entry. Figure 2
shows that SARSpp, containing SΔARO, are no longer capa-
ble of transducing Vero E6 cells, indicating that the aro-
matic domain is essential for the entry of the SARSpp.
Moreover, when all the tryptophan residues in the aro-
matic domain were replaced for alanines, SARSpp were
not infectious either, indicating that the alanines cannot
take over the role of the tryptophans during SARS S medi-
ated entry. This suggests a crucial role for the tryptophan
residues during SARS S- mediated entry.
Wimley and White have described an index on which the
membrane interfaciality of amino acids has been ranked
[16]. This index is indicative for the tendency of amino
acids to participate in the interface of membranes and
water. Tryptophan scores highest on this WW-index. Sec-
ond in this ranking is phenylalanine. To investigate
whether the high interfaciality of the tryptophans in the
aromatic domain was important for the entry-mediating
activity of the SARS S protein, we decided to replace one
or more tryptophans for phenylalanine residues, creating
mutants SW1→F, SW12→F, SW123→F, SW2→F, SW23→F, SW3→F,
and SW13→F. Figure 2A shows that replacing all three tryp-
tophan residues for phenylalanine (mutant SW123→F)
resulted in a total lack of SARSpp entry. Also the mutant S
proteins containing two out of three phenylalanine in
stead of tryptophan (mutants SW12→F, SW23→F, and
SW13→F) were not capable of mediating entry of SARSpp.
Only the mutants containing one phenylalanine replacing
a tryptophan (SW1→F, SW2→F, and SW3→F) had some resid-
ual entry-mediating activity (up to 30% for SW2→F). This
clearly shows that the tryptophan residues in the aromatic
domain of SARS S play a very specific role during entry of
SARSpp that cannot be taken over by the phenylalanine
residues. Therefore, the high propensity to participate in
the interface between water and membrane is probably
not the only feature of the tryptophan residues that is
involved in mediation of SARSpp entry, although it can-
not be ruled out at this time. To exclude the possibility of
a defect in protein maturation or incorporation into
SARSpp, all aromatic domain mutants were analyzed for
trimerization and incorporation efficiency. All mutants
were incorporated efficiently into SARSpp and were able
to trimerize (Figures 2B and 2C).Virology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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Characteristics of the SARS coronavirus S protein TMD and adjacent sequences Figure 1
Characteristics of the SARS coronavirus S protein TMD and adjacent sequences. A) Alignment of the TMDs and 
adjacent sequences of coronavirus S proteins. A representative of each coronavirus group is included in the alignment. Num-
bering is based on the SARS CoV sequence. Abbreviations: MHV, mouse hepatitis virus; HCoV, human coronavirus; TGEV, 
transmissible gastroenteritis virus; IBV, infectious bronchitis virus. B) Overview of the SARS CoV S mutant proteins that were 
generated for this study and their nomenclature.
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Aromatic-domain is involved in pore dilation
Tryptophans play an important role during GP41 medi-
ated fusion of the HIV membrane and its target mem-
brane. In particular, tryptophan residues have been
implicated in the process of fusion pore dilation, i.e. the
enlargement of a fusion pore [7,8]. How this exactly works
is poorly understood. We decided to test several mutants
of the aromatic domain for their capacity to mediate cell-
cell fusion and induce fusion pore formation. For these
particular experiments, we decided to use mutants of the
aromatic domain in the context of a deleted C-terminus
(SΔC27). This would yield a higher amount of S molecules
on the surface of the cell, thereby potentially increasing
the window of the cell-cell fusion assay [17]. Therefore,
mutants SΔARO/ΔC27 and SW123→A/ΔC27 were created and
used in a cell-cell fusion experiment, together with SWT
and SΔC27 as controls. In Figure 3, pictures are shown of
syncytia, representative for the cultures, induced by S or
mutant S molecules. SWT clearly induced rounded syncy-
tia consisting of approximately 50 cells, as determined by
the number of nuclei. SΔC27 was able to induce much
larger, rounded syncytia, with at least twice as many nuclei
as SWT, indicative for the high concentration of SΔC27 at
the surface of the cell. In contrast, syncytia induced by
SΔARO/ΔC27 and SW123→A/ΔC27 contained only a few cells
and had an irregular shape, compared to SWT or SΔC27
induced syncytia. Cells seemed to form small groups, but
with a different morphology than the positive controls,
indicating that the cell-fusion mediating activity was
altered. Rather, the cells seemed to stick together, yet not
Capacity of S proteins with mutations in the aromatic domain to mediate entry of SARSpp into VeroE6R cells Figure 2
Capacity of S proteins with mutations in the aromatic domain to mediate entry of SARSpp into VeroE6R cells. 
A) Titers of the mutant S containing pseudoparticles are shown as a percentage of wild type S containing pseudoparticles. B) 
Incorporation of S proteins in pseudoparticles. Equal amounts of [35S]-labeled particles, based on RT activity, were subjected to 
immunoprecipitation, using an S-specific antibody. The precipitates were analyzed using SDS-PAGE and subsequent autoradiog-
raphy. C) Trimers of S protein were shown by running the precipitates of B on a non reducing gel, without boiling of the sam-
ples.
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to fuse. These results were confirmed by mixing L-ACE2
cells (L cells stably expressing human ACE2 after transfec-
tion with pFLACE2/T7RLuc [14,18] with 293T cells tran-
siently expressing S or S mutants. To measure the mixing
of the cell contents, L cells were stained green by CMFDA
(Invitrogen) and 293T cells were stained red by CMTPX
(Invitrogen). Since both these dyes are unable to transfer
spontaneously from one cell to another, co-staining of
cells is a measure for cell fusion. Large syncytia, staining
positive for both dyes, were formed with SWT and SΔC27,
whereas no co-staining was observed with SΔARO/ΔC27
and SW123→A/ΔC27, indicating a lack of fusion (Figure 4).
Previously, cells expressing aromatic-mutants of HIV-1
GP41 molecules have been shown to be unable to induce
syncytium formation, but were shown to induce fusion
pore formation, with a block in the dilation of the fusion
pore, as evidenced by the transfer of small dye molecules
from one cell to another [7,8]. We investigated the SARS S
aromatic mutants for their capacity to display a similar
Capacity of S proteins with mutations in the aromatic domain to mediate cell cell fusion or pore formation Figure 3
Capacity of S proteins with mutations in the aromatic domain to mediate cell cell fusion or pore formation. 
Cell cell fusion of 293T cells expressing ACE-2 and SARS CoV S, or S mutants. Cells were stained as described in the material 
and methods section. Red stain shows ACE-2 and green shows SARS CoV S protein. Cells expressing Swt or SΔC27 clearly 
formed syncitia, whereas the mutants SΔARO/ΔC27 and SW123→A/ΔC27 did not.
SWT SǻC27
SǻARO/ǻC27 SW123ĺA/ǻC27Virology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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Full cell cell fusion, as shown by exchange of intracellular dyes, unable to transfer spontaneously from one cell to another Figure 4
Full cell cell fusion, as shown by exchange of intracellular dyes, unable to transfer spontaneously from one cell 
to another. Double staining of a cell indicated full cell cell fusion. Pore formation does not result in dye exchange. L cells 
expressing ACE2 were stained green by CMFDA and 293T cells expressing (mutant) S were stained red by CMTPX.
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activity, i.e. the induction of fusion pores, yet the incapa-
bility to establish full cell fusion. S-expressing cells were
labeled with CMAC-blue, a dye that once it is present in
the cytoplasm, will be modified by cytosolic enzymes,
which makes it unable to transfer from one cell to
another. ACE-2 expressing cells were labeled with calcein,
which can be transferred from one cell to another through
fusion pores. Double fluorescent cells thus represented
the transfer of calcein from an ACE-2 expressing cell to an
S-expressing cell, thereby showing the existence of fusion
pores. In Figure 5, samples are shown of double fluores-
cent cells. As clearly shown, all mutants were able to form
fusion pores since they all showed double fluorescent
cells.
Introduction of lysines in the SARS S TMD
As shown in Figure 1A, the supposed TMD domain of
SARS S is quite long, especially when the locations of
charged residues, that usually define the borders of a
TMD, are considered. The N-terminal lysine (pos. 1193) is
located in the aromatic domain, whereas the C-terminal
lysine is located between cys box 1 and cys box 2 (pos.
1227). The number of amino acids between these two
lysines is 33, whereas a typical TMD consists of approxi-
mately 16-20 amino acids. In an attempt to map the
actual borders of the TMD of SARS S we constructed a
range of S mutants in which extra lysine residues were
introduced between the two previously mentioned
lysines. (see Figure 1B) with the idea that introduction of
a lysine in a hydrophobic (transmembrane) environment
would result in a defective protein, unable to establish
fusion. In addition, at two positions, we inserted lysines
rather than replacing the existing amino acids for lysine.
As controls, mutants with alanines in stead of the intro-
duced lysines were made. When these S mutants where
expressed, they could all be incorporated into SARSpp
(results not shown) and all were able to form trimers (not
shown), which indicates that all mutants matured cor-
Pore formation, as shown by the transfer of calcein Figure 5
Pore formation, as shown by the transfer of calcein. Cells expressing ACE-2 (calcein loaded, green) and (mutant) S 
(CMAC loaded, blue) were mixed and transfer of calcein from the ACE-2 expressing cells to the S-expressing cells was moni-
tored. Double staining indicated calcein transfer and thus the existence of fusion pores.
SWT SǻC27 SǻARO/ǻC27 SW123ĺA/ǻC27Virology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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rectly. However, the ability of some of the S mutants to
mediate entry of the SARSpp was seriously decreased (see
Figure 6).
Introducing a lysine directly downstream of the aromatic
domain yielded two fundamentally different outcomes.
When glycine 1201 was replaced for a lysine residue
(SG1201K), S mediated entry was 60% compared to entry
mediated by SWT, indicating that a charged residue could
be tolerated at this position. However, inserting a lysine
residue between G1201 and F1202 (Sins1202K) resulted
in a complete block of entry. To check whether this phe-
notype was the result of the charge of the lysine, an
alanine was inserted at the same position (Sins1202A). To
our surprise, this mutant also had a very low capacity to
mediate entry of SARSpp, indicating that not so much the
charge of the lysine was detrimental for the activity of the
spike protein, but rather the presence of an extra amino
acid at that position.
Introducing a lysine directly upstream of cys box 1, either
through replacement or insertion (mutants SL1216K and
Sins1217K), resulted in a very low entry activity, indicating
that at this position the charge of the lysine was not toler-
ated. Indeed, this was further confirmed by the SL1216A
control mutant that was even more active than SWT.
Introduction of lysines at the positions A1204, and S1221
resulted in a severe reduction in fusion mediating capacity
(≤ 30%), whereas mutants SV1210K and SS1224K were
hardly altered in their fusion mediating capacity. Both
A1204 and S1221 are probably located in highly hydro-
phobic regions that do not tolerate a charged residue.
Results with the SV1210K and SS1224K mutants suggest that
the amino acids at these positions are in a less hydropho-
bic environment in which the charge is tolerated. This
means that position 1210 is at the exact middle of the
membrane, a place where charged residues can be toler-
ated [19]. Likewise, S1224, located downstream of the
fourth cys residue of cys box 1, probably is not in the
membrane, since the lysine was tolerated at that position.
Altogether, we propose that the membrane spanning
domain of SARS S starts at F1202 and ends at S1224.
Discussion
The TMDs of viral fusion proteins are less well studied
than their ectodomain counterparts. For a long time the
TMDs have been appreciated solely for their anchoring
function. However, it has become clear that the anchoring
function of the TMDs is just one task. TMDs have now
been implicated in virus assembly, protein sorting, oli-
gomerization and fusion. Here, we report the importance
of the TMD of the SARS CoV spike protein for mediating
membrane fusion and entry.
Capacity of S proteins with lysine insertions or replacements in the TMD to mediate entry of SARSpp into VeroE6R Figure 6
Capacity of S proteins with lysine insertions or replacements in the TMD to mediate entry of SARSpp into 
VeroE6R. Titers of the mutant S containing pseudoparticles are shown as a percentage of wild type S containing pseudoparti-
cles.
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Lysine scanning mutagenesis
Mutagenesis by lysine insertion showed that at position
1201 a charged residue could be tolerated, indicating that
the aromatic domain is located outside the membrane.
Indeed, in HIV gp41, a lysine is present between the aro-
matic domain and the transmembrane domain. However,
surprisingly, the lysine was tolerated only when it was a
replacement and not an insertion. Further investigation
showed that insertion of any amino acid at that position
results in a non-functional S protein, which suggests that
the positioning of the aromatic domain and the trans-
membrane domain relative to each other is crucial for
membrane fusion activity of SARS S.
The fact that mutant SS1221K is incorporated in SARSpp
implies that during maturation the cys box 1 does not
need to enter a hydrophobic environment. However, it
does not support fusion, suggesting that at some point
after fusion activation, the cys box 1 is supposed to enter
the viral membrane. This hints towards a model in which
the long TMD has a dynamic nature which ensures that
the lateral position of the helical TMD in the membrane
can be varied, depending on the stage of the fusion proc-
ess.
Role of tryptophan residues during SARS CoV membrane 
fusion activity
The tryptophan mutants are severely crippled in their
capacity to mediate SARSpp entry and induce cell-cell
fusion, confirming data recently published [15,20]. The
more tryptophans are lacking in the aromatic domain, the
less active the spikes are in their entry-mediating capacity.
In contrast, previously, mutant W1 → F was shown to be
completely inactive (mutant W1194F, [20]), whereas we
found approximately 17% activity. This difference cannot
be explained, but it is conceivable that a single mutant
would exhibit residual activity, as compared to double or
triple mutants. In Figures 3, 4 and 5, we show that
mutants that do not have tryptophans in the aromatic
domain, are unable to support entry of SARSpp, yet are
capable of initializing membrane fusion, i.e. capable of
forming a fusion pore. The aromatic domain of HIV GP41
has been suggested to be involved in dilation of the fusion
pore [7,8]. Saez-Cirion et al. have proposed two possible
mechanisms by which the tryptophan residues might pro-
mote pore dilation. The first model is that the tryptophans
enhance the transition between two lipidic stages of the
fusion process. The second model is that the tryptophanes
are involved in sequestering of multiple GP41 molecules
to establish a proteinaceous ring thereby promoting the
formation of a fusion pore [21]. Several studies are in sup-
port of the lipid model. Sainz Jr. et al have suggested that
during the conformational changes in the spike the aro-
matic domain might align the fusion peptide and the
TMD, thereby functioning as a hydrophobic sheet to
allow lipid flow between the two fusing membranes [22].
Other reports have shown that peptides, representing the
aromatic domain (of SARS CoV or HIV) are membrane
active and are capable of altering the biophysical proper-
ties of membranes [21,23-25]. Furthermore, tryptophan
residues have been shown to interact with cholesterol in
the membrane, thereby modulating membrane curvature,
possibly supporting lipidic intermediates during mem-
brane fusion [26]. Both the HIV GP41 and SARS CoV S
also contain a so-called CRAC motif (cholesterol recogni-
tion/interaction amino acid consensus) L/V-(X)(1-5)-Y-
(X)(1-5)-R/K, located upstream of the transmembrane
domain, which might also be of importance during mem-
brane fusion activity [27-30]. The sequestering of the aro-
matic domain is supported by the study that showed
oligomerization of HIV GP41 in solution [21]. Indeed,
when expressed in bacteria, the SARS S aromatic domain
forms hexamers in solution (J. Corver and W. Spaan,
unpublished observation). It has also been shown that
SARS CoV entry is dependent on the presence of lipid rafts
[31], which are known to be enriched in cholesterol, argu-
ing for the importance of cholesterol during SARS CoV
entry.
In this paper, we show that the function of the aromatic
domain of SARS CoV S is similar as the function of the
HIV GP41 aromatic domain, as evidenced by the same
phenotypic features of the mutants lacking tryptophan
residues. Replacement of the tryptophans by phenyla-
lanine residues resulted in a complete block of fusion
(Figure 3, 4, 5), suggesting that not only the interfaciality
of the tryptophans is important, but also other features. In
addition, we found that the distance between the aro-
matic domain and the TMD is critical, since insertion of
one amino acid resulted in a block of entry (Sins1202K
and Sins1202A). This suggests that the positioning of the
aromatic domain relative to the hydrophobic domain is
crucial for membrane fusion activity, a feature that was
not yet included in the model that tries to explain the role
of the aromatic domain in membrane fusion activity of
coronaviruses. We therefore like to propose a model into
which this new characteristic has been added.
Model
Based on the results described above and on results pub-
lished by others, we propose a mechanism in which the
lateral flexibility of the aromatic domain, the TMD
domain and the cys box 1 domain are pivotal for entry
(membrane fusion activity) of SARSpp and most likely
also SARS CoV. The model comprises the following steps
(see Figure 7): i) In the native mature spike protein, the
aromatic domain is folded into the ectodomain of the
spike. Previously, it has been shown that the aromatic
domain in native, prefusion GP41 is already associated to
the interface of the viral membrane [32], forming the feetVirology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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Proposed model of membrane fusion, mediated by SARS S Figure 7
Proposed model of membrane fusion, mediated by SARS S. The model predicts the lateral flexibility of the TMD and 
the adjacent aromatic and cysteine rich domains to accommodate the necessary intermediates during membrane fusion. Blue, 
aromatic domain; yellow, hydrophobic core; pink, cysteine rich domain, green triangles, cholesterol.Virology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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of the glycoprotein trimer tripod. However, the spikes on
SARS CoV do not show these typical feet or a tripod like
structure [33]. Therefore, it is possible that the position of
the aromatic domain of SARS CoV S is different in the
native conformation than in HIV GP41. The hydrophobic
central TMD is in the membrane and the cys box 1 is out-
side the membrane, but closely associated to the mem-
brane through the palmitic acids. ii) Once activated, the
spike refolds and initiates fusion. It folds back to form the
HR1-HR2 six helix bundle. As a result, the aromatic
domain becomes associated to the membrane interface
through its tryptophan residues, thereby pulling out the
hydrophobic core of the TMD and thus iii) pulling in the
cys box 1, which then partially becomes a transmem-
brane-like domain. Once released, the aromatic domain
oligomerizes and consequently the S proteins cluster. The
aromatic domain oligomerization also results in a cluster-
ing of cholesterol in the membrane, thereby inducing
bending of the membrane with a negative curvature.
Grouping of the S proteins, as induced by oligomerization
of the aromatic domain, would also be necessary to estab-
lish pore dilation, i.e. the transition from a pore to a real
fusion event, enabling large molecules to pass. Finally, as
shown previously, the glycines present in the hydropho-
bic central domain of SARS CoV S also play an important
role during entry [34], possibly by mediating bends in the
TMD needed for membrane fusion pore formation [6].
Bending of the central hydrophobic helix would fit in the
proposed model, enabling the positioning of the central
domain during the lipidic intermediate stages (stalk and
fusion pore).
Conclusions
Based on the results in this paper we conclude that the
aromatic rich region of the SARS CoV virus S protein plays
a crucial role in the entry of SARS CoV. Most likely, as
indicated in our model, the aromatic rich region is
involved in pore dilation, possibly through interactions
with cholesterol which modulate membrane curvature
and could support lipidic intermediates during mem-
brane fusion. In our model, we propose that the presence
of the aromatic domain and the cysteine rich domain
ensures a lateral flexibility of the S protein within the
membrane, that is necessary for induction of membrane
fusion. During this process, the positioning of the aro-
matic domain and the downstream amino acids relative
to each other is another crucial prerequisite in the entry
process of SARS CoV.
Methods
Cells and viruses
293T cells were obtained from the ATCC and cultured in
DMEM with 10% FCS, VeroE6R cells were a kind gift of
Dr. A.D.M.E. Osterhaus and they were cultured in DMEM
with 10% FCS. SARS CoV strain Frankfurt was a kind gift
of Drs H.F. Rabenau and H.W. Doerr.
Plasmids
The plasmids encoding SARS spike (phCMV-SS) and ACE-
2 (pFLACE-2/T7RLuc) were described before [14]. Plas-
mids encoding mutant spike proteins were created by
using the Quikchange method (Stratagene) and the prod-
ucts were verified by sequencing.
SARSpp synthesis and titer determination
Production of SARSpp was essentially carried out as
described before [35]. Briefly, transfection of 293T cells
with a set of retroviral Gag Pol expression constructs, a
GFP reporter plasmid and the SARS CoV spike mutant to
be expressed, was carried out using a CaCl2 transfection kit
(Clontech). Two days after transfection supernatants were
harvested and used to transduce VeroE6R cells. To correct
for the amount of retroviral particles per transduction a C-
type reverse transcriptase activity kit (Innovagen, Sweden)
was used. Four days after transduction, the percentage of
GFP positive cells was determined by FACS analysis on a
FACS Calibur (Becton-Dickinson).
Cell-cell fusion assays
Cell-cell fusion was measured in several assays. The basis
for all assays was the same, only the read-out was differ-
ent. For the immunofluorescence and dye transfer assay,
293T cells were transfected, using lipofectamine 2000
(Invitrogen) with plasmids encoding SARS S (or a
mutant) or the SARS CoV receptor, ACE-2 [14]. Twenty
four hours post transfection, cells were trypsinized, mixed
and plated on cover slips. After 24 hours incubation, the
assays were performed. The three different assays were:
immunofluorescence assay (IFA), dye-transfer assay and
cytoplasm mixing assay.
For the IFA, cells were mixed with a ratio of 1 to 4 (ACE-2
vs S respectively), fixed with 3.5% paraformaldehyde and
permeabilized with 0.1% triton X-100. Subsequently,
cells were incubated with goat anti ACE-2 antibody (R&D
systems). Next, the cells were incubated with FITC conju-
gated swine-anti rabbit antibody (both from Sigma) and
Hoechst. Then, the cells were incubated with rabbit-anti
spike antibody (a kind gift from Dr. Eickmann) and Cy5
conjugated Rabbit-anti goat antibody. Finally, the cells
were washed, mounted, and studied using a fluorores-
cence microscope (Zeiss).
For the dye transfer assay, trypsinized, transfected cells
were washed with PBS and resuspended in OptiMEM
(Invitrogen). Subsequently, calcein (Molecular probes,
Invitrogen) was added to the ACE-2 expressing cells to a
final concentration of 2 μM and CMAC (Molecular
probes, Invitrogen) was added to S expressing cells to aVirology Journal 2009, 6:230 http://www.virologyj.com/content/6/1/230
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final concentration of 20 μM. Cells were incubated for 45
minutes at 37°C, while being resuspended every 15 min-
utes. Subsequently, media were refreshed and cells were
transferred to clean tubes. After 30 minutes incubation at
37°C, cells were mixed in a 4 to 1 ratio (ACE-2 vs  S
expressing cells, respectively). Cells were then seeded on
coated microscope slides (Clearcell, cel-line, Erie scientific
company). After 24 hour incubation at 37°C, cells were
fixed with 3.5% paraformaldehyde and analyzed using a
fluorescence microscope (Zeiss).
For the cytoplasm mixing assay, L-ACE-2 cells, labeled
with CMFDA (Invitrogen) as described for CMAC, were
mixed with S-transfected 293T cells, labeled with CMTPX
(Invitrogen) as described for CMAC. The ratio of the cells
was 1 to 3 (S cells to ACE-2 cells, respectively). After 24
hours incubation, cells were fixed with 3.5% paraformal-
dehyde and analyzed by fluorescence microscopy.
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